L-carnitine administration reduces number of episodes in cyclic vomiting syndrome

Sandra C. Van Calcar; Cary O. Harding; Jon A. Wolff

doi:10.1177/000992280204100307

L-carnitine administration reduces number of episodes in cyclic vomiting syndrome

Sandra C. Van Calcar, Cary O. Harding, Jon A. Wolff

Molecular and Medical Genetics

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Abstract

Patients with cyclic vomiting syndrome suffer from recurring episodes of severe nausea and vomiting. This paper presents 6 patients who responded to 1-carnitine administration. Average time between episodes was 1.7 months before carnitine administration and increased to 1.1 years after carnitine administration. Average dose of carnitine administered was 50 mg/kg. Oral carnitine may be useful to control the symptoms in patients with cyclic vomiting syndrome.

Original language	English (US)
Pages (from-to)	171-174
Number of pages	4
Journal	Clinical pediatrics
Volume	41
Issue number	3
DOIs	https://doi.org/10.1177/000992280204100307
State	Published - 2002

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1177/000992280204100307

Cite this

@article{667c1f19386e4dbcbd7577de5601d2af,

title = "L-carnitine administration reduces number of episodes in cyclic vomiting syndrome",

abstract = "Patients with cyclic vomiting syndrome suffer from recurring episodes of severe nausea and vomiting. This paper presents 6 patients who responded to 1-carnitine administration. Average time between episodes was 1.7 months before carnitine administration and increased to 1.1 years after carnitine administration. Average dose of carnitine administered was 50 mg/kg. Oral carnitine may be useful to control the symptoms in patients with cyclic vomiting syndrome.",

author = "{Van Calcar}, {Sandra C.} and Harding, {Cary O.} and Wolff, {Jon A.}",

year = "2002",

doi = "10.1177/000992280204100307",

language = "English (US)",

volume = "41",

pages = "171--174",

journal = "Clinical pediatrics",

issn = "0009-9228",

publisher = "SAGE Publications Inc.",

number = "3",

}

TY - JOUR

T1 - L-carnitine administration reduces number of episodes in cyclic vomiting syndrome

AU - Van Calcar, Sandra C.

AU - Harding, Cary O.

AU - Wolff, Jon A.

PY - 2002

Y1 - 2002

N2 - Patients with cyclic vomiting syndrome suffer from recurring episodes of severe nausea and vomiting. This paper presents 6 patients who responded to 1-carnitine administration. Average time between episodes was 1.7 months before carnitine administration and increased to 1.1 years after carnitine administration. Average dose of carnitine administered was 50 mg/kg. Oral carnitine may be useful to control the symptoms in patients with cyclic vomiting syndrome.

AB - Patients with cyclic vomiting syndrome suffer from recurring episodes of severe nausea and vomiting. This paper presents 6 patients who responded to 1-carnitine administration. Average time between episodes was 1.7 months before carnitine administration and increased to 1.1 years after carnitine administration. Average dose of carnitine administered was 50 mg/kg. Oral carnitine may be useful to control the symptoms in patients with cyclic vomiting syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0036527024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036527024&partnerID=8YFLogxK

U2 - 10.1177/000992280204100307

DO - 10.1177/000992280204100307

M3 - Article

C2 - 11999680

AN - SCOPUS:0036527024

SN - 0009-9228

VL - 41

SP - 171

EP - 174

JO - Clinical pediatrics

JF - Clinical pediatrics

IS - 3

ER -

L-carnitine administration reduces number of episodes in cyclic vomiting syndrome

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this